These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9077481)
21. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin. Boiy A; Roelandts R; van den Oord J; de Witte PA Br J Dermatol; 2008 Feb; 158(2):360-9. PubMed ID: 18047507 [TBL] [Abstract][Full Text] [Related]
22. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer. Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734 [TBL] [Abstract][Full Text] [Related]
23. Comparative skin phototoxicity in mice with two photosensitizing drugs: benzoporphyrin derivative monoacid ring A and porfimer sodium (Photofrin). Wolford ST; Novicki DL; Kelly B Fundam Appl Toxicol; 1995 Jan; 24(1):52-6. PubMed ID: 7713343 [TBL] [Abstract][Full Text] [Related]
24. Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity. Obochi MO; Ratkay LG; Levy JG Transplantation; 1997 Mar; 63(6):810-7. PubMed ID: 9089219 [TBL] [Abstract][Full Text] [Related]
25. Spectral characterization of the benzoporphyrin derivative monoacid ring-A photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation. Gillies R; Kollias N; Hasan T; Diddens H J Photochem Photobiol B; 1996 Mar; 33(1):87-90. PubMed ID: 8786464 [TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth. Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659 [TBL] [Abstract][Full Text] [Related]
27. Wavelength-dependent effects of benzoporphyrin derivative monoacid ring A in vivo and in vitro. Waterfield EM; Renke ME; Smits CB; Gervais MD; Bower RD; Stonefield MS; Levy JG Photochem Photobiol; 1994 Oct; 60(4):383-7. PubMed ID: 7991665 [TBL] [Abstract][Full Text] [Related]
28. The killing effect of photodynamic therapy using benzoporphyrin derivative on retinoblastoma cell line in vitro. Jin C; Wu Z; Li Y; Li Y; Chen H; North J Yan Ke Xue Bao; 1999 Mar; 15(1):1-6. PubMed ID: 12579652 [TBL] [Abstract][Full Text] [Related]
29. Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures. Sakamoto FH; Doukas AG; Farinelli WA; Tannous Z; Su Y; Smith NA; Zurakowski D; Anderson RR Lasers Surg Med; 2011 Sep; 43(7):621-31. PubMed ID: 22057490 [TBL] [Abstract][Full Text] [Related]
30. Mitochondrion-targeted photosensitizer enhances the photodynamic effect-induced mitochondrial dysfunction and apoptosis. Peng TI; Chang CJ; Guo MJ; Wang YH; Yu JS; Wu HY; Jou MJ Ann N Y Acad Sci; 2005 May; 1042():419-28. PubMed ID: 15965088 [TBL] [Abstract][Full Text] [Related]
31. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222 [TBL] [Abstract][Full Text] [Related]
32. Targeting activated lymphocytes with photodynamic therapy: susceptibility of mitogen-stimulated splenic lymphocytes to benzoporphyrin derivative (BPD) photosensitization. Obochi MO; Canaan AJ; Jain AK; Richter AM; Levy JG Photochem Photobiol; 1995 Jul; 62(1):169-75. PubMed ID: 7638262 [TBL] [Abstract][Full Text] [Related]
33. Cellular distribution and phototoxicity of benzoporphyrin derivative and Photofrin. Rousset N; Vonarx V; Eléouet S; Carré J; Bourré L; Lajat Y; Patrice T Res Exp Med (Berl); 2000 Jun; 199(6):341-57. PubMed ID: 10945652 [TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. Taber SW; Fingar VH; Coots CT; Wieman TJ Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737 [TBL] [Abstract][Full Text] [Related]